Zoetis Price to Sales Ratio 2011-2021 | ZTS

Historical PS ratio values for Zoetis (ZTS) over the last 10 years. The current P/S ratio for Zoetis as of September 17, 2021 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zoetis P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2021-09-17 198.49 12.80
2021-06-30 186.13 $15.51 12.00
2021-03-31 157.05 $14.66 10.71
2020-12-31 164.80 $13.95 11.81
2020-09-30 164.46 $13.65 12.05
2020-06-30 136.10 $13.20 10.31
2020-03-31 116.70 $13.17 8.86
2019-12-31 131.04 $12.98 10.09
2019-09-30 123.20 $12.72 9.68
2019-06-30 112.06 $12.48 8.98
2019-03-31 99.24 $12.17 8.15
2018-12-31 84.16 $11.95 7.04
2018-09-30 89.96 $11.70 7.69
2018-06-30 83.58 $11.39 7.34
2018-03-31 81.81 $11.05 7.40
2017-12-31 70.45 $10.75 6.55
2017-09-30 62.26 $10.35 6.01
2017-06-30 60.92 $10.11 6.03
2017-03-31 51.93 $9.96 5.21
2016-12-31 51.98 $9.80 5.30
2016-09-30 50.40 $9.78 5.15
2016-06-30 45.99 $9.71 4.74
2016-03-31 42.78 $9.63 4.44
2015-12-31 46.15 $9.50 4.86
2015-09-30 39.58 $9.59 4.13
2015-06-30 46.27 $9.58 4.83
2015-03-31 44.34 $9.54 4.65
2014-12-31 41.14 $9.54 4.31
2014-09-30 35.26 $9.41 3.75
2014-06-30 30.73 $9.21 3.34
2014-03-31 27.49 $9.13 3.01
2013-12-31 30.98 $9.12 3.40
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $94.073B $6.675B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $54.271B 8.79
Astellas Pharma (ALPMY) Japan $31.799B 25.12
Merck (MKGAF) Germany $29.725B 23.14
Catalent (CTLT) United States $23.253B 49.15
Eisai (ESALY) Japan $23.025B 40.02
UCB SA (UCBJF) Belgium $20.036B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.759B 26.15
Ono Pharmaceutical (OPHLF) Japan $11.568B 15.31
Grifols, S.A (GRFS) Spain $10.443B 12.72
Neurocrine Biosciences (NBIX) United States $9.124B 25.94
United Therapeutics (UTHR) United States $8.988B 19.44
Evotec AG (EVTCY) Germany $8.646B 64.05
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.299B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.175B 9.43
IPSEN SA ADR (IPSEY) France $8.019B 0.00
STADA ARZNEIMI (STDAF) Germany $6.870B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.770B 0.00
Orion OYJ (ORINY) Finland $6.012B 25.98
Tilray (TLRY) United States $5.445B 0.00
Ionis Pharmaceuticals (IONS) United States $5.252B 0.00
Recursion Pharmaceuticals (RXRX) United States $4.517B 0.00
Hypermarcas (HYPMY) Brazil $3.972B 15.68
Turning Point Therapeutics (TPTX) United States $3.857B 0.00
Relay Therapeutics (RLAY) United States $3.438B 0.00
Nektar Therapeutics (NKTR) United States $3.035B 0.00
PTC Therapeutics (PTCT) United States $3.010B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.808B 0.00
Sage Therapeutics (SAGE) United States $2.729B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.696B 0.00
Pacira BioSciences (PCRX) United States $2.487B 27.56
Taro Pharmaceutical Industries (TARO) Israel $2.459B 16.45
Corcept Therapeutics (CORT) United States $2.378B 26.99
Revolution Medicines (RVMD) United States $2.298B 0.00
Cronos Group (CRON) Canada $2.230B 0.00
Organogenesis Holdings (ORGO) United States $2.142B 29.75
Indivior (INVVY) United States $2.067B 22.54
Xencor (XNCR) United States $2.016B 93.43
Ironwood Pharmaceuticals (IRWD) United States $2.012B 10.56
Trillium Therapeutics (TRIL) Canada $1.817B 0.00
USANA Health Sciences (USNA) United States $1.779B 13.41
AlloVir (ALVR) United States $1.562B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.522B 7.65
Vectura Group (VEGPF) United Kingdom $1.378B 0.00
Heron Therapeutics (HRTX) United States $1.233B 0.00
Sundial Growers (SNDL) Canada $1.204B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.181B 0.00
ImmunoGen (IMGN) United States $1.174B 0.00
ChemoCentryx (CCXI) United States $1.158B 0.00
Aclaris Therapeutics (ACRS) United States $1.112B 0.00
FibroGen (FGEN) United States $1.083B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.059B 0.00
VAXART, INC (VXRT) United States $1.033B 0.00
4D Molecular Therapeutics (FDMT) $0.939B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.879B 0.00
Zogenix (ZGNX) United States $0.848B 0.00
Ocular Therapeutix (OCUL) United States $0.808B 0.00
Bioventus (BVS) United States $0.789B 0.00
Collegium Pharmaceutical (COLL) United States $0.705B 16.52
Rigel Pharmaceuticals (RIGL) United States $0.666B 0.00
Endo (ENDP) Ireland $0.661B 1.07
Rafael Holdings (RFL) United States $0.653B 0.00
Silence Therapeutics (SLN) United Kingdom $0.648B 0.00
Summit Therapeutics (SMMT) United States $0.621B 0.00
Innate Pharma SA (IPHYF) France $0.619B 0.00
Aerie Pharmaceuticals (AERI) United States $0.611B 0.00
Altimmune (ALT) United States $0.605B 0.00
Radius Health (RDUS) United States $0.605B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.604B 0.00
Inotiv (NOTV) United States $0.558B 0.00
Chinook Therapeutics (KDNY) United States $0.556B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.522B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.520B 11.22
Siga Technologies (SIGA) United States $0.508B 12.31
Akebia Therapeutics (AKBA) United States $0.506B 0.00
Foghorn Therapeutics (FHTX) United States $0.489B 0.00
KalVista Pharmaceuticals (KALV) United States $0.470B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.468B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.466B 0.00
AVITA Medical (RCEL) United States $0.464B 0.00
Karyopharm Therapeutics (KPTI) United States $0.458B 0.00
Nanobiotix S.A (NBTX) France $0.443B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.443B 0.00
Jounce Therapeutics (JNCE) United States $0.399B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.399B 0.00
Esperion Therapeutics (ESPR) United States $0.353B 0.00
Acutus Medical (AFIB) United States $0.347B 0.00
Molecular Templates (MTEM) United States $0.336B 0.00
Viracta Therapeutics (VIRX) United States $0.324B 0.00
Infinity Pharmaceuticals (INFI) United States $0.322B 0.00
KemPharm (KMPH) United States $0.319B 0.00
Flexion Therapeutics (FLXN) United States $0.313B 0.00
Taiwan Liposome (TLC) Taiwan $0.305B 0.00
MEI Pharma (MEIP) United States $0.303B 0.00
PROFOUND MEDICL (PROF) Canada $0.298B 0.00
DURECT (DRRX) United States $0.298B 0.00
TherapeuticsMD (TXMD) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 12.18
ALLERGY THERAPT (AGYTF) United Kingdom $0.287B 0.00
Harpoon Therapeutics (HARP) United States $0.286B 0.00
CTI BioPharma (CTIC) United States $0.285B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.280B 0.00
Sierra Oncology (SRRA) United States $0.261B 0.00
Avalo Therapeutics (AVTX) United States $0.244B 0.00
Alpine Immune Sciences (ALPN) United States $0.239B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.236B 0.00
Redhill Biopharma (RDHL) Israel $0.228B 0.00
Clever Leaves Holdings (CLVR) United States $0.226B 0.00
Adherex Technologies (FENC) United States $0.220B 0.00
Oncternal Therapeutics (ONCT) United States $0.209B 0.00
Sigilon Therapeutics (SGTX) $0.196B 0.00
CASI Pharmaceuticals (CASI) United States $0.196B 0.00
Xeris Pharmaceuticals (XERS) United States $0.173B 0.00
Calithera Biosciences (CALA) United States $0.168B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.164B 0.00
Aquestive Therapeutics (AQST) United States $0.162B 0.00
Heat Biologics (HTBX) United States $0.162B 0.00
Novan (NOVN) United States $0.161B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.159B 0.00
Savara (SVRA) United States $0.158B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.153B 0.00
OptiNose (OPTN) United States $0.152B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.147B 0.00
IMV INC (IMV) Canada $0.143B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.142B 0.00
SCYNEXIS (SCYX) United States $0.141B 0.00
Qilian Holding Group (QLI) China $0.140B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Ardelyx (ARDX) United States $0.135B 0.00
Lannett Co Inc (LCI) United States $0.130B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
4D Pharma (LBPS) United Kingdom $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.122B 0.00
Concert Pharmaceuticals (CNCE) United States $0.119B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
Jaguar Animal Health (JAGX) United States $0.112B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.111B 0.00
Vivos Therapeutics (VVOS) $0.107B 0.00
Genocea Biosciences (GNCA) United States $0.105B 0.00
Recro Pharma (REPH) United States $0.104B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Otonomy (OTIC) United States $0.099B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.098B 0.00
AIM ImmunoTech (AIM) United States $0.098B 0.00
MediWound (MDWD) Israel $0.097B 0.00
IsoRay (ISR) United States $0.096B 0.00
Natural Alternatives (NAII) United States $0.096B 10.01
SHINECO INC (TYHT) China $0.095B 0.00
Gain Therapeutics (GANX) United States $0.094B 0.00
Aptorum Group (APM) United Kingdom $0.090B 0.00
Ainos (AIMD) United States $0.085B 0.00
Aziyo Biologics (AZYO) United States $0.084B 0.00
XPHYTO Therapeutics (XPHYF) Canada $0.083B 0.00
India Globalization Capital (IGC) United States $0.082B 0.00
HANCOCK JAFFE (HJLI) United States $0.082B 0.00
VYNE Therapeutics (VYNE) United States $0.081B 0.00
Onconova Therapeutics (ONTX) United States $0.081B 0.00
Progenity (PROG) United States $0.080B 0.00
ProPhase Labs (PRPH) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
Addex Therapeutics (ADXN) Switzerland $0.076B 0.00
Minerva Neurosciences (NERV) United States $0.073B 0.00
Regulus Therapeutics (RGLS) United States $0.069B 0.00
ElectroCore (ECOR) United States $0.067B 0.00
Brickell Biotech (BBI) United States $0.064B 0.00
PolarityTE (PTE) United States $0.063B 0.00
Mannatech (MTEX) United States $0.062B 10.52
Biomerica (BMRA) United States $0.058B 0.00
Nutriband (NTRB) United States $0.057B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.055B 0.00
Inhibikase Therapeutics (IKT) United States $0.051B 0.00
Baudax Bio (BXRX) United States $0.051B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.042B 70.00
Assertio Holdings (ASRT) United States $0.041B 0.00
AgeX Therapeutics (AGE) United States $0.038B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
Phio Pharmaceuticals (PHIO) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Plus Therapeutics (PSTV) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Petros Pharmaceuticals (PTPI) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 13.57
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
JanOne (JAN) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00